Rio Tinto Takes Majority Stake in Nemaska Lithium, Plans $300M Quebec Investment

BenzingaBenzinga
|||1 min read
Key Takeaway

Rio Tinto acquires majority stake in Nemaska Lithium, planning $300M Quebec investment to expand lithium operations amid growing EV demand.

Rio Tinto Takes Majority Stake in Nemaska Lithium, Plans $300M Quebec Investment

Rio Tinto has secured majority control of Nemaska Lithium with a 53.9% stake, marking a significant expansion of the mining company's lithium portfolio. The London-listed miner plans to deploy over $300 million in 2026 to develop integrated lithium operations in Quebec, positioning itself to capture growing demand from the battery and electric vehicle sectors.

The investment comes as Rio Tinto reported full-year earnings of $10.87 billion, trailing analyst expectations of $11.03 billion. The earnings miss was attributed to weakness in its iron ore segment, which faced headwinds from softer market conditions and operational challenges throughout the period.

Market reaction to the announcement proved mixed, with Rio Tinto's shares declining 3.20% during premarket trading. The selloff reflects investor concern over the lower-than-expected earnings results, though the company's strategic move into North American lithium production aligns with industry trends toward securing supply chains for battery metals.

Source: Benzinga

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

MVST Stock Plunges 34% After Disastrous Earnings; Law Firm Launches Fraud Investigation

Microvast ($MVST) plunged 34% after reporting $96.5M revenue (29% below consensus) and 1% gross margins, triggering securities fraud investigation by Pomerantz LLP.

MVSTMVSTW
Benzinga

KB Home Shares Slide on 23% Revenue Decline, Margin Compression in Q1

KB Home stock fell 4.8% after Q1 earnings missed expectations, with revenue down 23% year-over-year and operating margins compressed to 3.1%.

KBH
Investing.com

O'Reilly Automotive Hits 52-Week Low: Temporary Setback or Genuine Opportunity?

$ORLY hits 52-week low on narrow earnings miss despite 7.8% revenue growth and double-digit DIFM expansion. Analysts see 27% upside opportunity.

ORLY
Benzinga

ALIT Shareholders Face Class Action Deadline as Securities Fraud Lawsuit Claims Material Misstatements

$ALIT shareholders have until May 15, 2026 to join securities fraud lawsuit over alleged misstatements. Stock fell 18.3% and 38.2% after guidance misses in August 2025 and February 2026.

ALIT
The Motley Fool

Lenz Therapeutics Stock Crashes 11.2% on Missed Earnings and Weak VIZZ Launch

Lenz Therapeutics stock plummeted 11.2% after Q4 earnings miss, larger-than-expected losses, and disappointing VIZZ prescription uptake despite strong pipeline projections.

LENZ
The Motley Fool

Major Shareholder Trims $7.8M Harrow Stake, Signals Profit-Taking Over Retreat

Opaleye Management sold $7.8M in $HARR shares while retaining 10% stake, suggesting tactical rebalancing rather than loss of confidence in ophthalmic pharma company.

HROW